Transcatheter treatment of mitral and tricuspid valves - Kölner UniversitätsPublikationsServer

Gercek, Muhammed, Rudolph, Volker, Baldus, Stephan and Koerber, Maria Isabel (2021). Transcatheter treatment of mitral and tricuspid valves. Kardiologe, 15 (2). S. 109 - 115. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726

Full text not available from this repository.

DOI:10.1007/s12181-021-00458-9

Abstract

Transcatheter treatment of mitral and tricuspid regurgitation is an established option for patients deemed to be at high surgical risk. Next-generation devices and accumulated evidence of its safety and efficacy have made leaflet-based treatment a recommended therapy for primary and secondary mitral regurgitation in the most recent guidelines of the American College of Cardiology. In addition to leaflet-based devices, which have been used for several years, direct annuloplasty and transcatheter valve replacement are other available options. Major interest lies now in identification of predictive factors to improve patient quality of life and long-term-prognosis. Transcatheter treatment of the tricuspid valve is still in its early stages. However, leaflet-based devices as well as systems for direct annuloplasty have received CE marks. Evidence on safety and efficacy is growing and also data on postinterventional symptomatic improvement of patients is promising.

Item Type:

Journal Article

Creators:

Creators	Email	ORCID	ORCID Put Code
Gercek, Muhammed	UNSPECIFIED	UNSPECIFIED	UNSPECIFIED
Rudolph, Volker	UNSPECIFIED	UNSPECIFIED	UNSPECIFIED
Baldus, Stephan	UNSPECIFIED	UNSPECIFIED	UNSPECIFIED
Koerber, Maria Isabel	UNSPECIFIED	UNSPECIFIED	UNSPECIFIED